WEALTH EFFECTS LLC

Position in TGTX — Tg Therapeutics, Inc.

CIK 1907254 BOSTON, MA

Position in TGTX

as of Mar 31, 2026 · filed Apr 21, 2026 Compact

Position Value

$398,640

+$40,920 QoQ

Shares Held

12,000

0.0% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

WEALTH EFFECTS LLC holds $11,242,442 across 8 Biotechnology names. TGTX ranks #4 (3.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARWR	Arrowhead Pharmaceuticals, Inc.	143,300	$8,984,910
2	IBRX	ImmunityBio, Inc.	118,350	$907,744
3	ALT	Altimmune, Inc.	131,950	$406,406
4	TGTX	Tg Therapeutics, Inc. This page	12,000	$398,640
5	BEAM	Beam Therapeutics Inc.	10,100	$240,683
6	GLUE	Monte Rosa Therapeutics, Inc.	10,099	$166,128
7	HUMA	Humacyte, Inc.	204,500	$124,131
8	AUTL	Autolus Therapeutics plc	10,000	$13,800

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$398,640	12,000	0.0%	Shares	Sole	2026-04-21
2025-12-31	$357,720	12,000	0.0%	Shares	Sole	2026-01-26
2025-09-30	$433,500	12,000	+9.1%	Shares	Sole	2025-10-28
2025-06-30	$395,890	11,000	-4.3%	Shares	Sole	2025-07-15
2025-03-31	$453,445	11,500	-20.7%	Shares	Sole	2025-04-23
2024-12-31	$436,450	14,500	0.0%	Shares	Sole	2025-01-22
2024-09-30	$339,155	14,500	-12.1%	Shares	Sole	2024-10-21
2024-06-30	$293,535	16,500	0.0%	Shares	Sole	2024-08-02
2024-03-31	$250,965	16,500	+17.9%	Shares	Sole	2024-04-22
2023-12-31	$239,120	14,000	-9.7%	Shares	Sole	2024-01-29
2023-09-30	$129,580	15,500	—	Shares	Sole	2023-10-16
No filing history on record for this holder in this stock.